Scientists map how TB drugs work in the body to improve treatment
NCT ID NCT02563327
Summary
This study aimed to understand how the body processes two tuberculosis drugs, rifapentine and moxifloxacin, when given at high doses. Researchers measured drug levels in the blood of 53 adult TB patients to see if higher drug exposure led to better treatment results and fewer side effects. The goal was to use this information to help doctors prescribe the most effective and safest doses in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Joint Clinical Research Centre/ Makerere Univ Med Sch
Kampala, Uganda
-
National TB Program
Hanoi, Vietnam
-
University of Texas Health Science Center at
San Antonio, Texas, United States
Conditions
Explore the condition pages connected to this study.